Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: PEG

May 28, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo

Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited

Continue reading

April 13, 2026 Drug delivery / Pharma applications

Hydrogels for Cancer Immunotherapy

Cancer is a complex disease characterized by systemic dysfunction, necessitating a balance between therapeutic efficacy and safety. Immunotherapy is a

Continue reading

February 24, 2023 Drug delivery / Pharma applications

DDS for Dacarbazine by combining CD encapsulation with gold nanoparticles

Dacarbazine (DB) is an antineoplastic drug extensively used in cancer therapy. However, present limitations on its performance are related to

Continue reading

November 7, 2022 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin and folate functionalized polymer nanocarriers: Chain length dependent properties

A  series of β-cyclodextrin and folate-tethered poly(ethylene glycol) with various spacer chain lengths, prepared and characterized using spectroscopic methods. The

Continue reading

November 2, 2022 Pharma applications

Application of cyclodextrin/polyethylene glycol in blood-storage tools for liquid biopsy

In recent years, liquid biopsy has garnered considerable attention as a valuable diagnostic technology for cancer. An analysis target of

Continue reading

May 30, 2022 Drug delivery / Pharma applications

Poly(pseudo)rotaxanes formed by mixed micelles and α-cyclodextrin for drug delivery to the nail

This work aimed to develop water-based formulations for onychomycosis topical treatment using micelles of small pegylated surfactants associated with α-cyclodextrin

Continue reading

November 3, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Twenty years of research on cyclodextrin conjugates with PAMAM dendrimers

 Cyclodextrin (CD) conjugates with starburst polyamidoamine (PAMAM) dendrimer (CDEs), as a new type of polymer-based carriers, were first published in

Continue reading

September 6, 2019 CD derivatives / Drug delivery

Engineered cyclodextrin derivatives for spontaneous coating of highly porous metal-organic framework nanoparticles

Nanosized metal-organic frameworks (nanoMOFs) MIL-100(Fe) are highly porous and biodegradable materials that have emerged as promising drug nanocarriers. A challenging

Continue reading

September 4, 2019 Drug delivery / Pharma applications

HPBCD is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease

Niemann-Pick type C1 (NPC1) disease is a fatal neurovisceral disease for which there are no FDA approved treatments, though cyclodextrin

Continue reading

December 1, 2018 CD derivatives / Gene delivery / Pharma applications

Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery

In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed

Continue reading

Recent Posts

  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex – A Comparison of Analytical Techniques

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (427)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (230)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (411)
  • Other industrial use (111)
  • Pharma applications (1,206)
  • Supramolecular systems (44)
  • Uncategorized (164)

Top Posts

  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • International Cyclodextrin Symposium postponed to 2022
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • MANU-KAMU - Dog dental treats with cyclodextrin
  • Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
  • Meow! In Japan cyclodextrins are taking cat products to the next level! 😺
  • Japanese Supplement: Water with Health Benefits Combining Lactobacillus gasseri CP2305 with Alfa-Cyclodextrin
  • CPhI Japan
  • 10th Annual International Symposium of Drug Delivery Systems - 2022 (SDDS-2022)
  • CD researchers among the Best 100 Chemistry Scientists

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...